Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas 75390, USA; email:
Department of Gastroenterology, University of Michigan, Ann Arbor, Michigan 48109, USA; email:
Annu Rev Med. 2020 Jan 27;71:303-314. doi: 10.1146/annurev-med-050218-013625.
Irritable bowel syndrome (IBS) is the most prevalent of gastrointestinal (GI) conditions, affecting millions of people worldwide. Given that most IBS patients associate their GI symptoms with eating food, specific dietary manipulation has become an attractive treatment strategy. A diet low in FODMAPs (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) has generated the greatest level of scientific and clinical interest. Overall, 52-86% of patients report significant improvement of their IBS symptoms with elimination of dietary FODMAPs. Patients who experience symptom improvement with FODMAP elimination should undergo a structured reintroduction of foods containing individual FODMAPs to determine sensitivities and allow for personalization of the diet plan. This review discusses the literature surrounding the administration of the low-FODMAP diet and its efficacy in the treatment of IBS.
肠易激综合征(IBS)是最常见的胃肠道(GI)疾病之一,影响着全球数以百万计的人。鉴于大多数 IBS 患者将其胃肠道症状与进食联系起来,特定的饮食干预已成为一种有吸引力的治疗策略。低 FODMAP(可发酵的寡糖、双糖、单糖和多元醇)饮食引起了最大的科学和临床兴趣。总体而言,52-86%的患者报告说,通过消除饮食中的 FODMAP 可以显著改善他们的 IBS 症状。那些通过消除 FODMAP 而症状改善的患者应该进行个体化的饮食计划,重新引入含有单个 FODMAP 的食物,以确定敏感性。这篇综述讨论了低 FODMAP 饮食的文献及其在治疗 IBS 中的疗效。